India committed to collaborating with global stakeholders to address healthcare challenges: Piyush Goyal
India aims to collaborate internationally on healthcare challenges, offering unique talent and innovation. Union Commerce Minister Piyush Goyal highlighted India's role under PM Narendra Modi's leadership in transforming global healthcare through ...

Addressing BioAsia 2025, the premier life sciences and health-tech event organised by the Telangana government, he said India offers unmatched talent, cost advantages and a thriving innovation ecosystem.
He also emphasised that under Prime Minister Narendra Modi's leadership, India is driving innovations, fostering international collaborations, and accelerating the adoption of advanced technologies to transform healthcare delivery on a global scale.
India is recognised as the pharmacy of the world supplying affordable generics to over 200 countries.
"Today, we are making a significant transition from volume to value with a sharp focus on innovation, R &D and high value biopharma," he said.
With initiatives like the Production Linked Incentive (PLI) schemes for pharma, bulk drugs and medical devices, along with the Genome India project, Goyal said India is poised to lead the next wave of healthcare manufacturing.
In the recent budget, the government has announced significant concessions for cancer related and other life saving drugs, he pointed out.
As the country makes rapid progress under PM Modi's leadership, the people of Telangana are also benefiting from transformational reforms like Kakatiya Mega Textile Park in Warangal, industrial node in Zaheerabad and an AIIMS at Bibinagar, he added.
He also recalled the launch of the National Turmeric Board at Nizamabad.
Union Coal Minister G Kishan Reddy attended the valedictory session of the two-day event.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.